Novo Nordisk A/S
XMUN:NOVA

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
XMUN:NOVA
Watchlist
Price: 40.6 EUR Market Closed
Market Cap: 137.5B EUR

Wall Street
Price Targets

NOVA Price Targets Summary
Novo Nordisk A/S

Wall Street analysts forecast NOVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOVA is 62.25 EUR with a low forecast of 32.07 EUR and a high forecast of 103.46 EUR.

Lowest
Price Target
32.07 EUR
21% Downside
Average
Price Target
62.25 EUR
53% Upside
Highest
Price Target
103.46 EUR
155% Upside
Novo Nordisk A/S Competitors:
Price Targets
ZTS
Zoetis Inc
39% Upside
003850
Boryung Corp
32% Upside
OCS
Oculis Holding AG
112% Upside
4746
Formosa Laboratories Inc
76% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Novo Nordisk A/S

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's revenue is 12%. The projected CAGR for the next 4 years is 7%.

12%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novo Nordisk A/S

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's operating income is 15%. The projected CAGR for the next 4 years is 4%.

15%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Novo Nordisk A/S

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's net income is 15%. The projected CAGR for the next 4 years is 6%.

15%
Past Growth
6%
Estimated Growth
Estimates Accuracy
8%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NOVA's stock price target?
Price Target
62.25 EUR

According to Wall Street analysts, the average 1-year price target for NOVA is 62.25 EUR with a low forecast of 32.07 EUR and a high forecast of 103.46 EUR.

What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's revenue is 12%. The projected CAGR for the next 4 years is 7%.

What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's operating income is 15%. The projected CAGR for the next 4 years is 4%.

What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's net income is 15%. The projected CAGR for the next 4 years is 6%.

Back to Top